Cardiovascular effects of intravenous delta‐9‐tetrahydrocannabinol: Autonomic nervous mechanisms
- 1 April 1979
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 25 (4) , 440-446
- https://doi.org/10.1002/cpt1979254440
Abstract
The contribution of autonomic nervous system activity to the cardiovascular effects of delta-9-tetrahydrocannabinol (THC) was evaluated in 4 normal subjects. The peak heart rate rise after THC was attenuated by atropine and by propranolol, and nearly abolished by atropine-propranolol pretreatment. Blocking drugs also attenuated THC-induced changes in forearm blood flow and vascular resistance but did not affect changes in fingertip temperature. The data suggest that THC acts to induce sympathetic stimulation and parasympathetic inhibition of cardiovascular control pathways. Cardiovascular responses in an additional subject who developed hypertension after either intravenous or smoked marijuana are described.This publication has 6 references indexed in Scilit:
- Effects of Smoking Marihuana on Left Ventricular Performance and Plasma NorepinephrineAnnals of Internal Medicine, 1978
- Short-Term Effects of Smoked Marihuana on Left Ventricular Function in ManChest, 1977
- Prolonged delta‐9‐tetrahydrocannabinol ingestion; Effects of sympathomimetic amines and autonomic blockadesClinical Pharmacology & Therapeutics, 1977
- The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade.Circulation, 1976
- VASOCONSTRICTOR ACTIONS OF DELTA-8-TETRAHYDROCANNABINOL AND DELTA-9-TETRAHYDROCANNABINOL IN RAT1976
- The measurement of volume changes in human limbsThe Journal of Physiology, 1953